Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway

Zhao,Qingsong; Gao,Saiyue; Du,Qingyan; Liu,Ye

doi:10.3892/ijmm.2018.3819

Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway

Authors:
- Qingsong Zhao
- Saiyue Gao
- Qingyan Du
- Ye Liu
View Affiliations

Affiliations: Department of Urology, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Physical Examination Laboratory, Lanshan District Center for Disease Control and Prevention, Linyi, Shandong 276000, P.R. China, Clinical Laboratory, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China
Published online on: August 10, 2018 https://doi.org/10.3892/ijmm.2018.3819
Pages: 2839-2848

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The long non‑coding RNA, small nucleolar RNA host gene 20 (SNHG20), is involved in promoting several common types of human cancer, however, the exact function of SNHG20 in the pathogenesis of bladder cancer remains to be elucidated. The present study aimed to examine the regulatory mechanism of SNHG20 underlying the malignant progression of bladder cancer. Reverse transcription‑quantitative polymerase chain reaction and western blotting were used to examine mRNA and protein expression. Cell survival, proliferation, apoptosis, colony formation, migration and invasion were also studied. The resulting data indicated that SNHG20 was significantly upregulated in bladder cancer tissues and cell lines, compared with its expression in adjacent non‑tumour tissues and the SV‑HUC‑1 normal urinary tract epithelial cell line, respectively. In addition, the high expression of SNHG20 was associated with advanced clinical stage, lymph node metastasis, and reduced patient survival rate. The knockdown of SNHG20 caused a significant reduction in cancer cell survival, proliferation, colony formation, migration and invasion, and induced cell apoptosis. Additionally, the inhibition of SNHG20 reduced tumour growth in vivo. Investigations into the mechanism revealed that the inhibition of SNHG20 suppressed the activation of Wnt/β‑catenin signalling and the expression of certain key genes in bladder cancer cells. Taken together, these results indicated that SNHG20 is involved in promoting bladder cancer and may be used as a potential therapeutic target for the treatment of this disease.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Skeldon SC and Larry Goldenberg S: Bladder cancer: A portal into mens health. Urol Onco. 33:40–44. 2015. View Article : Google Scholar
3	Sathe A and Nawroth R: Targeting the PI3K/AKT/mTOR pathway in bladder cancer. Methods Mol Biol. 1655:335–350. 2018. View Article : Google Scholar
4	Li J, Zi Y, Wang W and Li Y: LncRNA MEG3 inhibits cell proliferation and metastasis in chronic myeloid leukemia via targeting miR-184. Oncol Res. 26:297–305. 2018. View Article : Google Scholar
5	Zhang JJ, Wang DD, Du CX and Wang Y: Long noncoding RNA ANRIL promotes cervical cancer development by acting as a sponge of miR-186. Oncol Res. May 22–2017.Epub ahead of print. View Article : Google Scholar
6	Yang M, Zhai X, Ge T, Yang C and Lou G: miR-181a-5p promotes proliferation and invasion, and inhibits apoptosis of cervical cancer cells via regulating inositol polyphosphate-5-phosphatase A (INPP5A). Oncol Res. 26:703–712. 2018. View Article : Google Scholar
7	Wang Y, Li J, Xu C and Zhang X: MicroRNA-139-5p inhibit cell proliferation and invasion by targeting RHO-associated coiled-coil containing protein kinase 2 in ovarian cancer. Oncol Res. Jun 14–2017.Epub ahead of print. View Article : Google Scholar
8	Liu L, Yu D, Shi H, Li J and Meng L: Reduced lncRNA aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/beta-catenin/mTOR/PI3K signaling. Pharmazie. 72:599–603. 2017.
9	Jia L, Tian Y, Chen Y and Zhang G: The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/beta-catenin pathway. Onco Targets Ther. 11:313–321. 2018. View Article : Google Scholar :
10	Xie H, Liao X, Chen Z, Fang Y, He A, Zhong Y, Gao Q, Xiao H, Li J, Huang W and Liu Y: LncRNA MALAT1 inhibits apoptosis and promotes invasion by antagonizing miR-125b in bladder cancer cells. J Cancer. 8:3803–3811. 2017. View Article : Google Scholar : PubMed/NCBI
11	Hu Y, Deng C, Zhang H, Zhang J, Peng B and Hu C: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/beta-catenin signaling pathway in bladder cancer. Oncotarget. 8:94554–94568. 2017.PubMed/NCBI
12	Zhai X and Xu W: Long noncoding RNA ATB promotes proliferation, migration and invasion in bladder cancer by suppressing microRNA-126. Oncol Res. Jan 10–2018.Epub ahead of print. View Article : Google Scholar
13	Wang M, Guo C, Wang L, Luo G, Huang C, Li Y, Liu D, Zeng F, Jiang G and Xiao X: Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. Cell Death Dis. 9:2382018. View Article : Google Scholar : PubMed/NCBI
14	Liu J, Lu C, Xiao M, Jiang F, Qu L and Ni R: Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Biomed Pharmacother. 89:857–863. 2017. View Article : Google Scholar : PubMed/NCBI
15	Zhang D, Cao C, Liu L and Wu D: Up-regulation of LncRNA SNHG20 predicts poor prognosis in hepatocellular carcinoma. J Cancer. 7:608–617. 2016. View Article : Google Scholar : PubMed/NCBI
16	Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B, Zhang T, Zhou Y, Chen Q, Wei C, et al: Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death Dis. 8:e30922017. View Article : Google Scholar : PubMed/NCBI
17	Li C, Zhou L, He J, Fang XQ, Zhu SW and Xiong MM: Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer. BMC Cancer. 16:6552016. View Article : Google Scholar : PubMed/NCBI
18	He S, Zhao Y, Wang X, Deng Y, Wan Z, Yao S and Shen H: Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling. Biosci Rep. 38:2018. View Article : Google Scholar
19	Liu J, Liu L, Wan JX and Song Y: Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3beta/beta-catenin signaling pathway. Oncotarget. 8:80700–80708. 2017.PubMed/NCBI
20	Guan YX, Zhang ZM, Chen XZ, Zhang Q, Liu SZ and Zhang YL: Lnc RNA SNHG20 participated in proliferation, invasion and migration of breast cancer cells via miR-495. J Cell Biochem. Dec 13–2017.Epub ahead of print. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Huang T, Liu HW, Chen JQ, Wang SH, Hao LQ, Liu M and Wang B: The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. Biomed Pharmacother. 88:302–308. 2017. View Article : Google Scholar : PubMed/NCBI
23	Xue M, Pang H, Li X, Li H, Pan J and Chen W: Long noncoding RNA UCA1 promotes bladder cancer cell migration and invasion via hsa-miR-145/ZEB1/2/FSCN1 pathway. Cancer Sci. 107:18–17. 2016. View Article : Google Scholar
24	Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X, Wang M, Huang C, Wang L, Zeng F and Jiang G: LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Cancer Lett. 388:281–291. 2017. View Article : Google Scholar
25	Maurya SK, Tewari M, Sharma B and Shukla HS: Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy. Korean J Intern Med. 28:573–578. 2013. View Article : Google Scholar : PubMed/NCBI
26	Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH, Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-kappaB1/MMP9 signaling pathway. Cancer Sci. 105:265–271. 2014. View Article : Google Scholar : PubMed/NCBI
27	Fife CM, McCarroll JA and Kavallaris M: Movers and shakers: Cell cytoskeleton in cancer metastasis. Br J Pharmacol. 171:5507–5523. 2014. View Article : Google Scholar : PubMed/NCBI
28	Mowers EE, Sharifi MN and Macleod KF: Functions of autophagy in the tumor microenvironment and cancer metastasis. FEBS J. 285:1751–1766. 2018. View Article : Google Scholar : PubMed/NCBI
29	Kapoor C, Vaidya S, Wadhwan V, Hitesh, Kaur G and Pathak A: Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther. 12:28–35. 2016. View Article : Google Scholar : PubMed/NCBI
30	Shen CH, Wu JD, Jou YC, Cheng MC, Lin CT, Chen PC, Tseng YS, Shi CS, Chen SY, Chang DC and Lee YR: The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer. J BUON. 16:733–737. 2011.
31	Schmitz-Drager BJ, Schulz WA, Jurgens B, Gerharz CD, van Roeyen CR, Bültel H, Ebert T and Ackermann R: c-myc in bladder cancer. Clinical findings and analysis of mechanism. Urol Res. 25(Suppl 1): S45–S49. 1997. View Article : Google Scholar : PubMed/NCBI
32	Mao XW, Xiao JQ, Li ZY, Zheng YC and Zhang N: Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3beta through the Wnt/beta-catenin signaling pathway. Exp Mol Med. 50:e4292018. View Article : Google Scholar
33	Yuan H, Yu S, Cui Y, Men C, Yang D, Gao Z, Zhu Z and Wu J: Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/beta-catenin signalling pathway. J Cell Mol Med. 21:3254–3263. 2017. View Article : Google Scholar : PubMed/NCBI
34	Mao XW, Xiao JQ, Xu G, Li ZY, Wu HF, Li Y, Zheng YC and Zhang N: CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/beta-catenin signaling pathway. Oncotarget. 8:77241–77253. 2017. View Article : Google Scholar : PubMed/NCBI
35	Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 280:4531–4538. 2013. View Article : Google Scholar
36	Costa VL, Henrique R, Ribeiro FR, Carvalho JR, Oliveira J, Lobo F, Teixeira MR and Jerónimo C: Epigenetic regulation of Wnt signaling pathway in urological cancer. Epigenetics. 5:343–351. 2010. View Article : Google Scholar : PubMed/NCBI
37	Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding Y, Hong D, Zhang D, He H, Sun L, et al: Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/beta-catenin/c-Myc signaling pathway in human gastric cancer cell. Biochem Pharmacol. 150:280–292. 2018. View Article : Google Scholar : PubMed/NCBI